Editas Medicine, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
EDIT on Nasdaq
Location
11 Hurley St., Cambridge, MA

Insiders trading volume in the past year

Editas Medicine, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michelle Robertson Evp, Chief Financial Officer $1.16M May 11, 2023
Gilmore O'Neill CEO, Director $1.07M -$805K -42.8% Sep 4, 2024
Bruce Eaton Evp, Cbo And Cto $815K -$8K -0.97% Dec 5, 2023
Mark Shearman Evp, Chief Scientific Officer $714K Feb 13, 2023
Erick Lucera Evp, Chief Financial Officer $656K -$125K -16.1% May 20, 2024
Baisong Mei Evp, Chief Medical Officer $459K -$230K -33.4% Sep 4, 2024
Linda Burkly Evp, Chief Scientific Officer $396K -$64.4K -14% Jul 25, 2024
Jessica Hopfield Director $382K +$254K +198% May 30, 2024
Lisa Michaels EVP/Chief Medical Officer $247K Dec 22, 2021
Elliott Levy Director May 30, 2024
Bernadette Connaughton Director May 30, 2024
James C. Mullen CEO, Director Apr 14, 2022
Andrew Hirsch Director May 30, 2024
David Scadden Director May 30, 2024
Emma Reeve Director May 30, 2024
Meeta Chatterjee Director May 30, 2024
Akshay Vaishnaw Director May 30, 2024

Recent Insider Transactions by Companies or Individuals for Editas Medicine, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.